A Phase II Multi Centre Study to Assess the Safety and Performance of Two Prototype One Piece Pouches in Subjects With an Ileostomy

Ileostomy Clinical Trial

— U366  

Official title:

A Phase II Multi Centre Study to Assess the Safety and Performance of Two Prototype One Piece Pouches in Subjects With an Ileostomy

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT01782196
• Other study ID #: CC-0512-12-U366
• Status: Terminated
• Phase: N/A
• First received: December 19, 2012
• Last updated: July 2, 2013
• Start date: October 2012
• Est. completion date: March 2013

Study information

• Verified date: July 2013
• Source: ConvaTec Inc.
• Contact: n/a
• Is FDA regulated: No
• Health authority: United Kingdom: Medicines and Healthcare Products Regulatory Agency
• Study type: Interventional

Clinical Trial Summary

Certain research and innovation projects require an assessment of the adhesive properties of adhesives, which cannot be established from in-vitro testing. The most valuable data for assessments of this type comes from adhesion and wear time studies involving application to living human skin on volunteers. The purpose of the study is to assess the safety and performance of an enhanced one piece drainable pouch with a mouldable skin barrier wafer in a group of subjects with an ileostomy.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 13
• Est. completion date: March 2013
• Est. primary completion date: March 2013
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Subjects who provide written informed consent.

• Subjects who have an ileostomy and be over 18 years of age.

• Subjects who are currently using a one piece drainable pouch.

• Subjects who have unbroken peri-stomal skin (healthy normal skin defined as "normal unbroken skin with certain variations normal for this subject" to L1 on the SACs Instrument Scale).

• Subjects with a stoma considered 'normal' in appearance in accordance with the stoma, colour, moisture and structure rating scales.

• Subjects who are willing to attend clinic for a maximum of 5 separate occasions for scheduled visits.

• Subjects who are willing to discontinue the use of pastes, adhesive strips and rings/seals used to seal the area between the skin barrier wafer and stoma during the use of the study device.

• Subjects who other than their ileostomy considered to have a healthy/stable health status.

• Subjects who have good manual dexterity and be able to take care of their stoma independently, or have a consistent care provider.

• Subjects who are willing and able to complete a diary card for the duration of the study.

Exclusion Criteria:

• Subjects with a history of sensitivity to any one of the ostomy products or the components being studied.

• Subjects with stoma duration of less than 3 months.

• Subjects who currently use a belt with their usual appliance.

• Subjects who have been entered into the study before, or who have previously taken part in a study in the last month.

• Subjects who require convexity or other skin fillers (pastes, rings, seals) to even undulations of the skin.

• Subjects undergoing chemotherapy or radiotherapy.

• Subjects who have any other medical condition which, according to the investigator justifies exclusion from the study.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care

Related Conditions & MeSH terms

• Ileostomy

Intervention

Device:
• Enhanced one piece drainable pouch with Type A mouldable adhesive

• Enhanced one piece drainable pouch with Type B mouldable adhesive

Locations

Country	Name	City	State
United Kingdom	Princess of Wales Hospital	Bridgend	Mid Glam
United Kingdom	Homerton University Hospital	London
United Kingdom	Musgrove Park Hospital	Taunton	Somerset
United Kingdom	Manor Hospital	Walsall	West Midlands
United Kingdom	Wrexham Maelor Hospital	Wrexham	North Wales

Sponsors (1)

Lead Sponsor	Collaborator
ConvaTec Inc.

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Safety - evaluated by the nature and frequency of adverse events including stomal and peristomal skin condition and lesions	The primary objective of this study is to evaluate the safety of the enhanced one piece drainable pouch with a mouldable skin barrier wafer and two alternate adhesives in subjects with an ileostomy.	59 days	Yes
Secondary	Performance	Performance will be evaluated by comparing the following categories to the subject's usual pouching system; Wear time Adhesion Ease of Use Mouldability Comfort and flexibility Security Skin protection Wafer seal integrity Undermining Filter performance Accessory usage; At the end of the study a comparative assessment of the subject's usual pouching system and the study pouch will be made.	59 days	No